{"id":"https://openalex.org/W4362595264","doi":"https://doi.org/10.1158/1538-7445.am2023-4674","title":"Abstract 4674: Patient-derived xenograft (PDX) and corresponding cell line models from glioblastoma for drug development, immuno-oncology and translational research","display_name":"Abstract 4674: Patient-derived xenograft (PDX) and corresponding cell line models from glioblastoma for drug development, immuno-oncology and translational research","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362595264","doi":"https://doi.org/10.1158/1538-7445.am2023-4674"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-4674","doi":"https://doi.org/10.1158/1538-7445.am2023-4674","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-4674","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082600012","display_name":"Joshua Alcaniz","orcid":"https://orcid.org/0009-0009-2959-1653","observed_orcids":["https://orcid.org/0009-0009-2959-1653"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua Alcaniz","raw_affiliation_strings":["1EPO GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055523748","display_name":"Lars Winkler","orcid":"https://orcid.org/0000-0003-3350-1189","observed_orcids":["https://orcid.org/0000-0003-3350-1189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lars Winkler","raw_affiliation_strings":["1EPO GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024016239","display_name":"Maria Stecklum","orcid":"https://orcid.org/0009-0001-7951-5730","observed_orcids":["https://orcid.org/0009-0001-7951-5730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Stecklum","raw_affiliation_strings":["1EPO GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113556991","display_name":"Hagen Wieland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hagen Wieland","raw_affiliation_strings":["2PromoCell, Heidelberg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2PromoCell, Heidelberg, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108616773","display_name":"Antje Siegert","orcid":"https://orcid.org/0000-0001-8874-8109","observed_orcids":["https://orcid.org/0000-0001-8874-8109"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antje Siegert","raw_affiliation_strings":["1EPO GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060122908","display_name":"Michael A. Becker","orcid":"https://orcid.org/0000-0002-9706-905X","observed_orcids":["https://orcid.org/0000-0002-9706-905X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Becker","raw_affiliation_strings":["1EPO GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090624000","display_name":"Bernadette Brzezicha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bernadette Brzezicha","raw_affiliation_strings":["1EPO GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031474036","display_name":"Wolfgang Walther","orcid":"https://orcid.org/0000-0003-2360-1370","observed_orcids":["https://orcid.org/0000-0003-2360-1370"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Walther","raw_affiliation_strings":["3Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002682008","display_name":"Jens Hoffmann","orcid":"https://orcid.org/0000-0003-3880-1658","observed_orcids":["https://orcid.org/0000-0003-3880-1658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jens Hoffmann","raw_affiliation_strings":["1EPO GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GmbH, Berlin, Germany;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"4674","last_page":"4674"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9739999771118164},{"id":"https://openalex.org/keywords/glioblastoma-cell-lines","display_name":"glioblastoma cell lines","score":0.8989999890327454},{"id":"https://openalex.org/keywords/drug-sensitivity-screening","display_name":"drug sensitivity screening","score":0.7210000157356262},{"id":"https://openalex.org/keywords/temozolomide-resistance","display_name":"temozolomide resistance","score":0.8539999723434448},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.8600000143051147},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7870000004768372},{"id":"https://openalex.org/keywords/orthotopic-xenograft-model","display_name":"orthotopic xenograft","score":0.7250000238418579},{"id":"https://openalex.org/keywords/tumor-molecular-profiling","display_name":"tumor molecular profiling","score":0.5479999780654907},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8230000138282776},{"id":"https://openalex.org/keywords/idh-wildtype-glioma","display_name":"IDH-wildtype glioma","score":0.6010000109672546},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.87107253074646},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6965474486351013},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6797351241111755},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.6224918365478516},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5759006142616272},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5288651585578918},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5184154510498047},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.47578346729278564},{"id":"https://openalex.org/C128473837","wikidata":"https://www.wikidata.org/wiki/Q7863603","display_name":"U87","level":3,"score":0.4712919294834137},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4414439797401428},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4227047562599182},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4135749936103821},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4096914529800415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29517993330955505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2787732481956482},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20745283365249634},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-4674","doi":"https://doi.org/10.1158/1538-7445.am2023-4674","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-4674","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4364381647","https://openalex.org/W2885385295","https://openalex.org/W4254675757","https://openalex.org/W2739493201","https://openalex.org/W2810568692","https://openalex.org/W2588635922","https://openalex.org/W7110666801","https://openalex.org/W4416141456","https://openalex.org/W2394896056","https://openalex.org/W4393075714"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Glioblastoma":[2,71],"(GBM)":[3],"is":[4,53,330],"the":[5,66,86,107,170,198,268,321,356,403],"most":[6,57],"common":[7],"malignant":[8],"brain":[9],"tumor":[10,50,158],"in":[11,59,62,94,99,190,195,213,222,232,261,311,346],"adults,":[12],"with":[13,197,258,288],"about":[14],"90%":[15],"of":[16,29,32,38,48,69,89,123,135,169,285,324,358,402],"tumors":[17],"developing":[18],"de":[19],"novo.":[20],"Their":[21,271],"heterogeneity,":[22],"aggressiveness":[23],"and":[24,36,61,83,146,151,164,167,176,183,188,192,224,247,266,278,326,335,385,396,415],"infiltrative":[25],"growth":[26,184,236,295],"limit":[27],"success":[28],"current":[30],"standard":[31],"care":[33],"(SoC)":[34],"therapy":[35],"efficacy":[37],"new":[39,359],"therapeutic":[40],"approaches.":[41],"For":[42],"drug":[43,91,144,181,299,333,393],"development":[44,92,334],"a":[45,341],"large":[46],"panel":[47,122,150],"patient-derived":[49,75],"cell":[51,72,159,343,387],"models":[52,113,127,140,171,209,226,234,254,351,389],"needed":[54],"to":[55,84,97],"generate":[56],"comparable":[58],"vitro":[60,95,191,347],"vivo":[63,100,196],"platform":[64,323],"reflecting":[65],"complex":[67],"biology":[68],"glioblastoma.":[70],"lines":[73,160,344],"from":[74,93,390],"xenografts":[76],"(PDX)":[77,384],"preserve":[78],"many":[79],"patient":[80],"specific":[81],"characteristics":[82],"perform":[85],"essential":[87],"steps":[88],"pre-clinical":[90],"screening":[96],"orthotopic":[98,225,327],"approaches":[101],"under":[102],"conditions,":[103],"which":[104],"closely":[105],"resemble":[106,274],"clinical":[108],"situation.":[109],"Further,":[110,283],"GBM":[111,207,280,286,314,328],"PDX":[112,126,200,208,287,315,329],"are":[114],"useful":[115],"for":[116,143,210,242,332,345,355,392,406],"immune":[117],"oncology":[118],"research.":[119,398],"Methods:":[120],"A":[121],"26":[124],"glioblastoma":[125,391],"was":[128,172,186,220],"established":[129,137,163,322],"on":[130],"immunodeficient":[131],"mice":[132],"(15":[133],"out":[134],"these":[136,350],"orthotopically).":[138],"All":[139],"were":[141,161,240,305],"characterized":[142],"sensitivity":[145,182,212,300],"molecular":[147,281],"profile":[148],"using":[149],"transcriptome":[152],"sequencing.":[153],"From":[154],"these,":[155],"three":[156],"corresponding":[157,386],"successfully":[162],"characterized.":[165],"Quality":[166],"identity":[168],"performed":[173,221],"by":[174,340],"FACS":[175],"PCR":[177],"analysis.":[178],"Expression":[179],"profile,":[180],"behavior":[185],"determined":[187],"compared":[189],"after":[193],"re-transplantation":[194],"original":[199],"glioma":[201],"model.":[202],"In":[203,298],"addition,":[204],"we":[205],"employed":[206],"checkpoint-inhibitor":[211],"humanized":[214],"mouse":[215],"settings.":[216],"Results:":[217],"Drug":[218],"testing":[219],"s.c.":[223,233,325],"revealed,":[227],"that":[228,320],"best":[229],"treatment":[230,284,309],"responses":[231],"(tumor":[235],"inhibition":[237],">":[238],"50%)":[239],"observed":[241],"SoC":[243],"temozolomide":[244],"(TMZ),":[245],"irinotecan":[246,302],"bevacizumab.":[248],"Molecular":[249],"characterization":[250],"identified":[251,306],"all":[252],"our":[253],"as":[255,307],"IDH-wt":[256],"(R132)":[257],"frequent":[259],"mutations":[260],"PARP1,":[262],"EGFR,":[263],"TP53,":[264],"FAT1,":[265],"within":[267],"PI3K/AKT/mTOR":[269],"pathway.":[270],"expression":[272],"profiles":[273],"proposed":[275],"mesenchymal,":[276],"proneural":[277],"classical":[279],"subtypes.":[282],"ipilimumab,":[289],"nivolumab":[290],"or":[291,303],"pembrozolumab":[292],"generated":[293],"minor":[294],"delay.":[296],"Conclusions:":[297],"screening,":[301],"bevacizumab":[304],"alternative":[308],"options":[310],"TMZ":[312],"resistant":[313],"models.":[316],"Our":[317],"data":[318],"demonstrate,":[319],"valuable":[331],"can":[336,352],"well":[337],"be":[338,353],"complemented":[339],"PDX-derived":[342],"screens.":[348],"Furthermore,":[349],"used":[354],"evaluation":[357],"immune-oncology":[360],"therapies.":[361],"Citation":[362],"Format:":[363],"Joshua":[364],"Alcaniz,":[365],"Lars":[366],"Winkler,":[367],"Maria":[368],"Stecklum,":[369],"Hagen":[370],"Wieland,":[371],"Antje":[372],"Siegert,":[373],"Michael":[374],"Becker,":[375],"Bernadette":[376],"Brzezicha,":[377],"Wolfgang":[378],"Walther,":[379],"Jens":[380],"Hoffmann.":[381],"Patient-derived":[382],"xenograft":[383],"line":[388],"development,":[394],"immuno-oncology":[395],"translational":[397],"[abstract].":[399],"In:":[400],"Proceedings":[401],"American":[404],"Association":[405],"Cancer":[407,426],"Research":[408],"Annual":[409],"Meeting":[410],"2023;":[411],"Part":[412],"1":[413],"(Regular":[414],"Invited":[416],"Abstracts);":[417],"2023":[418],"Apr":[419],"14-19;":[420],"Orlando,":[421],"FL.":[422],"Philadelphia":[423],"(PA):":[424],"AACR;":[425],"Res":[427],"2023;83(7_Suppl):Abstract":[428],"nr":[429],"4674.":[430]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}